As of Jan 16, 2025, Ambev S.A. Intrinsic Value is $2.7. This suggests it may be undervalued by 50.0% compared to its current price of around $1.8.
As of Jan 16, 2025, Ambev S.A.'s Discounted Cash Flow (DCF) valuation estimates its share price at $3.0. This suggests it may be overvalued by 67.2% to its current price of around $1.8, using a discount rate of 12.2% and terminal growth rate of 2.0%.
Ambev S.A. is currently considered undervalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $2.7, compared to a market price of around $1.8. This suggests a potential undervaluation of 50.0%.